Pulmonary hypertension - Hemodynamic diagnosis and management

被引：28
作者：
Chatterjee, K
De Marco, T
Alpert, JS
机构：
[1] Univ Calif San Francisco, Chatterjee Ctr Cardiac Res, Sch Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Heart Failure & Pulm Hypertens Program, Sch Med, San Francisco, CA 94143 USA
[3] Univ Arizona, Hlth Sci Ctr, Dept Med, Tucson, AZ USA
来源：
ARCHIVES OF INTERNAL MEDICINE | 2002年 / 162卷 / 17期
关键词：
D O I：
10.1001/archinte.162.17.1925
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hemodynamic classification of pulmonary hypertension relates to the hemodynamic mechanisms of pulmonary arterial hypertension, such as abnormalities of pulmonary blood flow, pulmonary vascular resistance, and pulmonary venous pressures. The therapeutic approaches can be directed to the hemodynamic mechanisms of pulmonary hypertension.
引用
收藏
页码：1925 / 1933
页数：9
相关论文
共 57 条
[31]   Pulmonary hypertension in chronic liver disease [J].
Mandell, MS ;
Groves, BM .
CLINICS IN CHEST MEDICINE, 1996, 17 (01) :17-&
[32]   LONG-TERM CLINICAL-RESULTS AFTER VASODILATOR EVALUATION IN PATIENTS WITH PRIMARY (UNEXPLAINED) AND SECONDARY PRECAPILLARY PULMONARY-HYPERTENSION - ACUTE HEMODYNAMIC COMPARISONS AND LONG-TERM SURVIVAL [J].
MCKAY, CR ;
BRUNDAGE, BH ;
PORTS, TA ;
PARMLEY, WW ;
CHATTERJEE, K .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1989, 22 (03) :311-319
[33]   Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension [J].
McLaughlin, VV ;
Genthner, DE ;
Panella, MM ;
Rich, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05) :273-277
[34]   Cor pulmonale [J].
Emil D. Missov ;
Teresa De Marco .
Current Treatment Options in Cardiovascular Medicine, 2000, 2 (2) :149-158
[35]   Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension [J].
Nagaya, N ;
Uematsu, M ;
Okano, Y ;
Satoh, T ;
Kyotani, S ;
Sakamaki, F ;
Nakanishi, N ;
Miyatake, K ;
Kunieda, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (04) :1188-1192
[36]   Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred [J].
Newman, JH ;
Wheeler, L ;
Lane, KB ;
Loyd, E ;
Gaddipati, R ;
Phillips, JA ;
Loyd, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (05) :319-324
[37]   EFFECTS OF INTRAVENOUS-INFUSION OF PROSTACYCLIN (PGI2) IN MAN [J].
OGRADY, J ;
WARRINGTON, S ;
MOTI, MJ ;
BUNTING, S ;
FLOWER, R ;
FOWLE, ASE ;
HIGGS, EA ;
MONCADA, S .
PROSTAGLANDINS, 1980, 19 (02) :319-332
[38]   Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation [J].
Okada, K ;
Bernstein, ML ;
Zhang, W ;
Schuster, DP ;
Botney, MD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (03) :939-950
[39]   Primary pulmonary hypertension [J].
Stuart Rich .
Current Treatment Options in Cardiovascular Medicine, 2000, 2 (2) :135-139
[40]   PRIMARY PULMONARY-HYPERTENSION - A NATIONAL PROSPECTIVE-STUDY [J].
RICH, S ;
DANTZKER, DR ;
AYRES, SM ;
BERGOFSKY, EH ;
BRUNDAGE, BH ;
DETRE, KM ;
FISHMAN, AP ;
GOLDRING, RM ;
GROVES, BM ;
KOERNER, SK ;
LEVY, PC ;
REID, LM ;
VREIM, CE ;
WILLIAMS, GW .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (02) :216-223
123456